Bio-Rad Laboratories (NYSE:BIO.B) Reaches New 52-Week Low – Here’s What Happened

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) shares hit a new 52-week low on Monday . The company traded as low as $241.99 and last traded at $241.99, with a volume of 110 shares changing hands. The stock had previously closed at $265.82.

Bio-Rad Laboratories Stock Performance

The company has a quick ratio of 4.85, a current ratio of 6.48 and a debt-to-equity ratio of 0.18. The stock has a market capitalization of $6.78 billion, a PE ratio of -3.72 and a beta of 0.75. The firm has a 50 day moving average price of $306.59 and a 200-day moving average price of $324.17.

Bio-Rad Laboratories (NYSE:BIO.B) last released its quarterly earnings data on Thursday, February 13th. The company reported $2.90 earnings per share for the quarter. Bio-Rad Laboratories had a negative net margin of 71.86% and a positive return on equity of 3.90%.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.